Climate change, urbanization, and the increased movement of people and goods are contributing to the spread of arboviral diseases, according to Polaris Market Research. The arbovirus testing market was valued at USD 1.31 billion in 2025 and is projected to grow at a CAGR of 4.70% from 2026 to 2034, reaching USD 1.98 billion by 2034. This article examines the surveillance, technology, and supply considerations that support that outlook, along with the regional picture in Asia Pacific.

Government Programs and Arboviral Disease Surveillance

Strengthening arboviral disease surveillance is a recurring theme in the report. In March 2022, the World Health Organization announced the launch of the Global Arbovirus Initiative, intended to tackle emerging arboviruses with epidemic and pandemic potential. The report also points to the increasing number of government initiatives aimed at managing the burden of arboviral diseases, along with rising investment in research and development of new diagnostic products and growing awareness programs by various organizations. Recent advancements in clinical diagnostics, together with these government initiatives, are expected to propel market growth during the forecast timeframe.

Artificial intelligence is expected to support this effort. The report notes that AI can support arboviral disease surveillance by monitoring outbreak trends, predicting transmission risks, and mapping geographic distribution. It can also improve the efficiency of test processes in laboratories and health agencies, and accelerate diagnosis by recognizing patterns within laboratory test results and helping clinicians interpret complicated information.

Isothermal Amplification and Faster Molecular Methods

The development of newer molecular methods that perform assays at a constant temperature, removing the need for expensive thermal cycling equipment, is expected to benefit the market. According to the report, isothermal amplification times have now been reduced in most cases to 5 to 20 minutes. Faster methods fit into a competitive landscape where product development is a priority.

The market is moderately competitive. Small and medium-sized companies are expected to improve their market shares owing to increasing investments in research and development for rapid tests and new product launches. For example, in November 2021, Achiko AG announced the initiation of development of a DNA aptamer-based dengue fever diagnostic test.

Chikungunya Testing and Asia Pacific Growth

The report analyzes the market by test type, arboviral disease, end use, and region, with a regional scope covering North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is anticipated to register the highest CAGR, at 5.4%, during the forecast period. The report attributes this to a growing patient pool suffering from arboviral diseases such as dengue, yellow fever, and chikungunya, government initiatives promoting the benefits of early detection, and companies' increased focus on untapped markets in the region. Data from India's National Center for Vector Borne Diseases Control show 93,455 suspected chikungunya cases in India in 2023, a figure that illustrates the scale of the diagnostic need behind chikungunya testing in the region.

Early testing is also described as beneficial for patients, and the report lists increasing incidences of dengue, yellow fever, and chikungunya among the factors expected to contribute to market expansion.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

https://www.polarismarketresearch.com/industry-analysis/arbovirus-testing-market 

Zika Virus and the Wider Disease Mix

The disease segmentation includes dengue, yellow fever, Zika virus, chikungunya, and others. Dengue held a 51.3% share in 2025, reflecting a large patient pool and growing dengue mortalities. The report notes that AI can enhance the diagnosis of diseases such as dengue, Zika virus, and chikungunya by analyzing diagnostic data faster and more accurately. Arboviruses are spread to humans and other vertebrates primarily through flies, mosquitoes, and ticks, and people in tropical and subtropical areas are at greater risk owing to warm temperatures and humidity.

Diagnostic Reagents and Supply Chain Resilience

The effectiveness and efficiency of testing systems depend directly on access to high-quality raw materials, including diagnostic reagents, antibodies, primers, enzymes, and specific consumables used in ELISA and RT-PCR tests. A reliable supply chain is crucial for ongoing surveillance of and response to outbreaks, especially during peak transmission periods.

Disruptions in the supply chain, the use of specialist suppliers, and fluctuations in the availability of diagnostic reagents can affect laboratories' capacity to perform tests. Manufacturers are working to improve regional supply chains, build up in-house reagent production capacities, and optimize their supply chain operations. Continuous raw material access is crucial for rapid and accurate diagnosis of mosquito-transmitted viral infections around the world.

Key Players in the Arbovirus Testing Market

The report lists these major players: Abbott (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Copley Scientific (UK), DiaSorin SpA (Italy), Euroimmun AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), NovaTec Immundiagnostica GmbH (Germany), QIAGEN N.V. (Netherlands), and Thermo Fisher Scientific, Inc. (U.S.).

Conclusion

Surveillance, rapid molecular methods, and dependable access to inputs are central to the arbovirus testing market's outlook. Government initiatives, AI-assisted analysis, isothermal amplification, and the disease burden from chikungunya, dengue, and Zika virus all feature in the report's discussion, while supply chain resilience for diagnostic reagents remains essential for laboratories. With a projected value of USD 1.98 billion by 2034 and Asia Pacific expected to grow fastest, the report offers stakeholders a practical view of where demand is building.

More Trending Latest Reports By Polaris Market Research:

Autonomous Port Operations Systems Market

Insecticides Market

Remote Monitoring and Control Market

Biodiversity Credit Market

U.S. Rockets and Missiles Market

Psoriasis Drug Market

Fuel Cell Market

Automotive Wiring Harness Market

Dc Distribution Network Market